Literature DB >> 20878164

[Genetic and risk factors for exudative AMD].

M Dietzel1, A Farwick, H-W Hense.   

Abstract

Age-related macular degeneration (AMD) is a complex disease of the central retina and the most important cause of blindness in the elderly. Exudative AMD in particular is responsible for cases of rapidly progressive visual impairment. Knowledge of pathogenetic mechanisms in exudative AMD is of particular importance for individual prognosis and the development of preventive and therapeutic options. Apart from age, smoking is the only consistently found major modifiable risk factor. Exudative AMD has a clear genetic basis with variants in the CFH and ARMS2 genes as major contributors. While ARMS2 seems to primarily influence the progression to exudative AMD, CFH seems equally related to the development of the exudative and atrophic forms of late AMD. Further differences relating to genetic and environmental risk factors in subgroups of exudative AMD are to be expected from future studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878164     DOI: 10.1007/s00347-010-2141-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  30 in total

1.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

2.  Progress in understanding and treating age-related macular degeneration.

Authors:  A Lotery
Journal:  Eye (Lond)       Date:  2008-06       Impact factor: 3.775

Review 3.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

4.  A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.

Authors:  Zhenglin Yang; Nicola J Camp; Hui Sun; Zongzhong Tong; Daniel Gibbs; D Joshua Cameron; Haoyu Chen; Yu Zhao; Erik Pearson; Xi Li; Jeremy Chien; Andrew Dewan; Jennifer Harmon; Paul S Bernstein; Viji Shridhar; Norman A Zabriskie; Josephine Hoh; Kimberly Howes; Kang Zhang
Journal:  Science       Date:  2006-10-19       Impact factor: 47.728

5.  Genotypic influences on severity of exudative age-related macular degeneration.

Authors:  Nicolas Leveziel; Nathalie Puche; Florence Richard; John E A Somner; Jennyfer Zerbib; Sylvie Bastuji-Garin; Salomon Y Cohen; Jean-François Korobelnik; José Sahel; Gisèle Soubrane; Pascale Benlian; Eric H Souied
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

6.  Susceptibility genes and progression in age-related maculopathy: a study of single eyes.

Authors:  Astrid Farwick; Jürgen Wellmann; Monika Stoll; Daniel Pauleikhoff; Hans-Werner Hense
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

7.  Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration.

Authors:  Milam A Brantley; Sean L Edelstein; Jennifer M King; Rajendra S Apte; Steven M Kymes; Alan Shiels
Journal:  Am J Ophthalmol       Date:  2007-07-12       Impact factor: 5.258

8.  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.

Authors:  Milam A Brantley; Amy M Fang; Jennifer M King; Asheesh Tewari; Steven M Kymes; Alan Shiels
Journal:  Ophthalmology       Date:  2007-12       Impact factor: 12.079

9.  The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.

Authors:  John Paul SanGiovanni; Emily Y Chew; Traci E Clemons; Frederick L Ferris; Gary Gensler; Anne S Lindblad; Roy C Milton; Johanna M Seddon; Robert D Sperduto
Journal:  Arch Ophthalmol       Date:  2007-09

10.  CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD.

Authors:  Kristinn P Magnusson; Shan Duan; Haraldur Sigurdsson; Hjorvar Petursson; Zhenglin Yang; Yu Zhao; Paul S Bernstein; Jian Ge; Fridbert Jonasson; Einar Stefansson; Gudleif Helgadottir; Norman A Zabriskie; Thorlakur Jonsson; Asgeir Björnsson; Theodora Thorlacius; Palmi V Jonsson; Gudmar Thorleifsson; Augustine Kong; Hreinn Stefansson; Kang Zhang; Kari Stefansson; Jeffrey R Gulcher
Journal:  PLoS Med       Date:  2005-11-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.